Testing Times

Dr Victor Chua, Partner at Mansfield Advisors, looks at the potential for increased M&A activity and outsourcing in the independent pathology market In our last article, we looked at Monitor’s proposals to drastically cut the tariff for non-emergency orthopaedic procedures. It looks like the proposal has been taken off the table for now. On 6th January 2016, Monitor published a new draft tariff workbook. Instead of rebalancing the tariff by increasing some specialities and decreasing others, it looks like an average 1% increase across all procedures. This is good news for the independent sector.